1. Home
  2. UPC vs PPBT Comparison

UPC vs PPBT Comparison

Compare UPC & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • PPBT
  • Stock Information
  • Founded
  • UPC 1998
  • PPBT 2010
  • Country
  • UPC China
  • PPBT Israel
  • Employees
  • UPC N/A
  • PPBT N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPC Health Care
  • PPBT Health Care
  • Exchange
  • UPC Nasdaq
  • PPBT Nasdaq
  • Market Cap
  • UPC 2.2M
  • PPBT 2.1M
  • IPO Year
  • UPC 2021
  • PPBT N/A
  • Fundamental
  • Price
  • UPC $4.23
  • PPBT $0.60
  • Analyst Decision
  • UPC
  • PPBT Strong Buy
  • Analyst Count
  • UPC 0
  • PPBT 1
  • Target Price
  • UPC N/A
  • PPBT $33.00
  • AVG Volume (30 Days)
  • UPC 94.4K
  • PPBT 2.9M
  • Earning Date
  • UPC 04-29-2025
  • PPBT 11-14-2025
  • Dividend Yield
  • UPC N/A
  • PPBT N/A
  • EPS Growth
  • UPC N/A
  • PPBT N/A
  • EPS
  • UPC N/A
  • PPBT N/A
  • Revenue
  • UPC $19,293,003.00
  • PPBT N/A
  • Revenue This Year
  • UPC N/A
  • PPBT N/A
  • Revenue Next Year
  • UPC N/A
  • PPBT N/A
  • P/E Ratio
  • UPC N/A
  • PPBT N/A
  • Revenue Growth
  • UPC N/A
  • PPBT N/A
  • 52 Week Low
  • UPC $2.51
  • PPBT $0.53
  • 52 Week High
  • UPC $600.00
  • PPBT $13.95
  • Technical
  • Relative Strength Index (RSI)
  • UPC 60.24
  • PPBT 32.32
  • Support Level
  • UPC $3.32
  • PPBT N/A
  • Resistance Level
  • UPC $4.49
  • PPBT $2.36
  • Average True Range (ATR)
  • UPC 0.50
  • PPBT 0.14
  • MACD
  • UPC 0.06
  • PPBT -0.10
  • Stochastic Oscillator
  • UPC 46.43
  • PPBT 25.54

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Share on Social Networks: